Bradley attorneys represented the management group in a management-led buyout of a life sciences business in a transaction worth tens of millions of dollars. The company produces a cancer diagnostic test that helps doctors personalize treatment options to the specific circumstances their patients are facing and, given the ongoing growth of the cancer treatment market, is positioned to expand in both its size and value following the buyout.
Management buyouts are complex transactions that necessitate high-quality legal work that includes providing structuring advice based on optimal tax results, drafting and negotiating transaction documents related to the acquisition, drafting the offering memorandum, and coordinating equity holders rolling over equity into the new entity. At the same time the transaction is underway, the management team has to continue to run the business, meaning they must place a good deal of trust in the lawyers handling the legal matters of the buyout. To provide effective counsel to management teams, attorneys must possess a deep understanding of both the underlying business and the goals of the investors to guide them toward practical solutions and achieve their desired outcomes.
Bradley’s experienced corporate attorneys guided the company's management team in a successful buyout. The firm applied its deep knowledge of corporate and securities laws and transactions to ensure that the clients were able to raise the capital they needed and structure the transaction in compliance with all applicable laws and regulations. As a result, the deal closed in late 2015, and the management team has an opportunity to grow their equity while guiding the company forward in the exciting field of cancer diagnostics.
